Kristie L. Kahl is vice president of content at MJH Life Sciences, overseeing CURE®, CancerNetwork®, the journal ONCOLOGY, Targeted Oncology, and Urology Times®. She has been with the company since November 2017.
She is a graduate of Rider University, where she acquired a Bachelors of Art in journalism, as well as a graduate of Temple University, where she received her Masters of Science in Sports Management.
Follow Kristie on Twitter at @KristieLKahl, or email her at [email protected].
Knowing Ones Rights When Working After a Cancer Diagnosis
May 30th 2023As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about working during a cancer diagnosis and its treatments, and what rights individuals have when it comes to employment and insurance.
Read More
How to Prepare for Extended Time off From Work During a Cancer Journey
May 30th 2023As part of its Speaking Out video series, CURE spoke with Joanna Fawzy Morales, Esq., from Triage Cancer, about policies around taking extended time off from work for patients with cancer and their caregivers.
Read More
Adding Nubeqa to Therapy May Reduce PSA Levels in Metastatic Hormone-Sensitive Prostate Cancer
May 1st 2023Men with metastatic hormone-sensitive prostate cancer treated with Nubeqa, androgen-deprivation therapy and docetaxel had reductions in PSA levels that were associated with improved overall survival and a prolonged time to PSA progression.
Read More
Educated Patient® Breast Cancer Summit at MBCC HER2-Positive Disease Panel: March 4, 2023
March 2nd 2023Watch Dr. Naomi Dempsey, Dr. Ana Sandoval Leon, Dr. Rupesh Kotecha and Ricki Fairley answer questions about HER2-positive disease during the CURE Educated Patient® Breast Cancer Summit at MBCC.
Read More
Educated Patient® Multiple Myeloma Summit Treating Myeloma Long-Term Panel: November 13, 2022
December 6th 2022Watch Valarie Traynham, of the HealthTree Foundation, discuss the long-term journey of the disease and disparities still seen during the CURE® Educated Patient® Multiple Myeloma Summit.
Read More